Exploring the clinical relevance of a dichotomy between affective and non-affective psychosis: results from a first episode psychosis cohort study by Ramain, J. et al.
 
 
Exploring the clinical relevance of a dichotomy between affective and non-
affective psychosis: results from a first episode psychosis cohort study 
 
Julie Ramain1*, Philippe Conus1, Philippe Golay1,2 
 
 
1. Service of General Psychiatry, Treatment and Early Intervention in Psychosis Program (TIPP-
Lausanne), Lausanne University Hospital and University of Lausanne, Switzerland. 
2. Institute of Psychology, Faculty of Social and Political Sciences, University of Lausanne, 
Switzerland. 
Running title: Affective and non-affective psychosis dichotomy 
 
* Corresponding author: Julie Ramain. Lausanne University Hospital (CHUV), Place Chauderon 18, 
1003 Lausanne, Switzerland. Email: julie.ramain@chuv.ch 
  
Abstract 
Aim: Defining diagnosis is complex in early psychosis, which may delay the introduction of an 
appropriate treatment. The dichotomy of affective and non-affective psychosis is used in clinical setting 
but lacks scientific basis. In this study, we explore the clinical relevance of this dichotomy on the basis 
of clinical variables in a sample of first episode psychosis patients.  
Method: We conducted a prospective study in a sample of 330 first episode psychosis treated at an 
early intervention program. Affective and non-affective psychosis patients were compared on premorbid 
history, baseline data, outcomes and course of symptoms over the three years of treatment. 
Results: Affective psychosis patients (22.42%) were more likely to be female, and had a shorter 
duration of untreated psychosis. The longitudinal analyses revealed that positive symptoms remained 
higher over the entire follow-up in the non-affective sub-group. A higher degree of variability of manic 
symptoms and a significantly better insight after 6 months were observed in the affective sub-group. No 
difference were observed regarding depressive and negative symptoms. At discharge, only the 
environmental quality of life and insight recovery were better in affective psychosis. 
Conclusions: Our study suggests that despite marginal differences at baseline presentation, these 
sub-groups differ regarding outcome, which may require differentiation of treatment and supports the 
utility of this dichotomy.  
Key words: early medical intervention, mood disorders, patient outcome assessment, psychotic 
disorders, symptom assessment  
1. Introduction 
Affective and non-affective psychoses are nosological entities derived from Kraepelin’s dichotomy 
(Kraepelin, 1992) between schizophrenia (dementia preacox) and psychotic mood disorders (manic-
depressive insanity). Although understudied (Chia et al., 2019; Conus & McGorry, 2002), affective 
psychosis is a concept applied in clinical settings referring to forms of psychoses marked by a severe 
disturbance of mood (Kraepelin, 1992; Lambert, Conus, Lambert, & McGorry, 2003). It has emerged 
as a way to stratify patients on the basis of clinical presentation, grouping bipolar disorder with psychotic 
features, major depression with psychotic features and schizoaffective disorder as “affective psychoses”, 
schizophrenia and schizophreniform disorders as non-affective psychoses (Lambert et al., 2003). In 
order to provide early intervention adjusted to the specificities of psychotic disorders, this dichotomy is 
nowadays used in treatment guidelines (Lambert et al., 2003). Indeed, the co-occurrence of mood 
episodes and psychotic features in affective psychosis may require pharmacotherapy considering both 
dimensions. However, this dichotomy is mainly based on clinical observations and definitions rather 
than scientific evidence suggesting the need to further investigate their psychopathological differences. 
Although schizophrenia and bipolar disorder have been identified as distinct entities through 
dichotomous classifications, more and more papers point towards a continuum between both entities 
with prototypic forms of each disorder at the extremes but a majority of people expressing mixed forms 
(Keshavan et al., 2011; Thaker, 2008). Such studies highlight the limitations of a categorical 
classification of mental disorders and the need for a more dimensional concept based on clinico-
pathological factors, and especially including longitudinal follow-up (Craddock & Owen, 2007; 
Keshavan et al., 2011; Thaker, 2008). This way of thinking boundaries between disorders would not 
only provide a distinction of clinical utility but, would also enable to cluster individuals sharing similar 
features that do not correspond to the prototypical forms of these disorders (Craddock & Owen, 2007). 
This point is especially crucial in first episode psychosis as studies highlighted a spectrum of disorders 
rather than discrete diagnostic entities, making diagnostic categorisation and treatment intervention even 
trickier due to both blurred boundaries and instability of diagnosis in this phase of illness (Conus et al., 
2010; McGorry, 1994; Schimmelmann, Conus, Edwards, McGorry, & Lambert, 2005; Shinn et al., 
2017). Indeed, diagnostic classifications are usually based on studies conducted in chronic samples, and 
therefore are not well adapted to early phases of disorders (McGorry, 1994; McGorry et al., 1995). 
Dimensional and longitudinal symptom assessment may thus provide a helpful way of identifying 
differences between diagnostic groups in the early phase of illness (Arrasate et al., 2014).  
Although limited, there is some research data suggesting the existence of factors differing between 
affective and non-affective psychosis, and that the study of this dichotomy may provide elements to 
improve early diagnosis accuracy, and thus treatment management (Kapila et al., 2019; Schothorst, 
Emck, & van Engeland, 2006). First, some authors suggested that distinctive characteristics can be 
observed at baseline within first episode cohorts. Indeed, previous studies suggest that patients with 
affective psychosis were more likely to be women, had a higher level of education, were less likely to 
be single, had a shorter duration of untreated psychosis (DUP), an older age at onset, were less likely to 
attempt suicide, were more likely to have a past history of psychiatric disorder and substance use, and 
had a better premorbid functioning and adjustment (Conus, Cotton, Schimmelmann, McGorry, & 
Lambert, 2007; Kapila et al., 2019; Schothorst et al., 2006). Second, regarding psychopathological 
features, Kapila et al. (2019) pointed out fewer psychotic symptoms, but more manic symptoms in first 
episode manic psychosis than in schizophrenia spectrum psychosis at baseline. Another naturalistic 
longitudinal prospective study showed that the affective psychosis sub-group had less negative but more 
manic symptoms at baseline than the non-affective one (Torrent et al., 2018). At two-year follow-up, 
these differences had decreased but the affective psychosis sub-group displayed less positive, negative 
and general symptoms as well as less depressive symptoms. Similarly, Henry et al. (2010) found lower 
general psychopathology scores and fewer psychotic symptoms after two-year follow-up in affective 
psychosis. They also highlighted differences in psychotic illness course (episodic vs continuous) which 
may require specific intervention. Considering recovery, although Banayan, Papetti, Palazzolo, 
Pringuey, and Darcourt (2007) reported better functioning, symptomatic remission and quality of life at 
follow-up in the affective psychosis sub-group, they found no difference between sub-groups regarding 
employment and time living independently.  
Considering both the paucity of data and the clinical relevance of the dichotomy between affective and 
non-affective psychoses in order to guide treatment in the early phase of psychosis, and following the 
suggestion by Craddock and Owen (2007) we investigated this topic with a longitudinal approach using 
different symptom dimensions with the following aims : 1) to consolidate previous results regarding 
baseline characteristics and outcomes differences between affective and non-affective psychoses; (2) to 
investigate differences between both groups regarding the course of symptoms in the early phase of 
psychosis. 
2. Method 
2.1  Sample and procedure 
This is a prospective study on a cohort of first episode psychosis patients treated at a specialized early 
psychosis intervention program, TIPP (Treatment and Early Intervention in Psychosis Program), 
implemented in Lausanne (Switzerland) since 2004 at the CHUV’s Department of Psychiatry (Baumann 
et al., 2013; P. Conus & Bonsack, 2004). Patients entering the program are aged between 18 and 35, 
reside in the catchment area of Lausanne and have crossed the psychosis threshold according to the 
“Psychosis threshold” subscale of the Comprehensive Assessment of At Risk Mental States scale 
(CAARMS; Yung et al., 2005). Patients are directed to other programs if they have been on 
antipsychotic medication for more than 6 months, an intoxication or an organic brain disease induced 
psychosis, or if their intelligence quotient is lower than 70. In this program, every patient is followed 
for 3 years by a psychiatrist and a case manager. The TIPP program favours a bio-psycho-social 
perspective, and as such provides treatment that includes psychotherapy, psycho-education, family 
support and therapy, cognitive assessment and remediation, social support, supported employment, 
psychological interventions for cannabis use, and pharmacological treatment. In line with international 
guidelines, atypical antipsychotics are first-line pharmacological treatment with a prospective 
monitoring of any side effects (Baumann et al., 2013). Case managers fill out for every patient  a 
questionnaire specifically designed for the TIPP. This questionnaire gathers information about 
demographic characteristics, past medical history, exposure to life events, symptomatology and 
functioning. Follow-up assessments are carried out at 2, 6, 12, 18, 24, 30, and 36 months by a research 
psychologist and case managers, exploring various aspects of treatment, evolution of psychopathology 
and functional level, as well as co-morbidities (e.g. level of insight; treatment adherence; presence or 
absence of forensic history and substance use; intermittent exposure to trauma; suicide attempts and 
forensic events). This study was approved by the Human Research Ethics Committee of the Canton 
Vaud (protocol #2020-00272). The data generated by the follow-up of all patients were used in the study 
if they provided consent. All of them agreed for their clinical data to be used for research.  
2.2 Diagnostic Assessment 
Diagnosis results from an expert consensus discussed at 18 and 36 months, based on the DSM-IV criteria 
using the information from medical or hospitalization reports from treating psychiatrists, as well as from 
the TIPP-assigned psychiatrist and case manager. We used the latest consensus diagnostic available. 
Considering potential diagnostic instability in first-episode psychosis cohorts (Gale-Grant et al., 2020), 
we also examined the diagnostic stability between the first and the latest diagnosis. Patients diagnosed 
with bipolar disorder, major depression with psychotic features and schizoaffective disorder were 
included in the affective psychosis group, while those with schizophrenia or other schizophreniform 
disorders were included in the non-affective psychosis group. Considering the instability of the diagnosis 
of unspecified psychosis (Cawkwell, Bolton, Karmacharya, Öngür, & Shinn, 2020; Taş, Celik, & 
Altinbaş, 2019) and its unclear status between affective and non-affective psychoses, these patients were 
excluded. 
2.3 Socio-demographic and premorbid characteristics 
 
According to the CAARMS criteria, DUP was defined as the time elapsed from the onset of psychosis 
until admission to TIPP. Socioeconomic status (SES) was subdivided into three categories: low, 
intermediate and high (Chandola & Jenkinson, 2000). Independent living refers to patients living in 
independent households, living alone or with friends or family without supervision. The employment 
situation was subdivided into student or traineeship, active employment, which was defined as partial 
or full-time job, or other. The premorbid functional level was assessed with the Premorbid Adjustment 
Scale (PAS; Cannon-Spoor, Potkin, & Wyatt, 1982) using the childhood and early adolescence sub-
scores (MacBeth & Gumley, 2008), and the total score. We considered that patients had a history of 
trauma if they had experienced at least one instance of sexual or physical abuse before the onset of 
psychosis (Alameda et al., 2015; Alameda et al., 2016). We defined migration in adversity as migration 
occurring in adverse contexts (e.g. seeking protection for political reasons, threat of death, exposure to 
war or extreme poverty). Past psychiatric and substance abuse or dependence diagnoses were evaluated 
with DSM-IV criteria (American Psychiatric Association, 1994), and past suicide attempts with the ICD-
10 classification (Dilling & Dittmann, 1990). Forensic history included all types of offenses. Insight was 
rated by the case manager as being absent, partial, or full regarding awareness of illness and necessity 
of treatment. 
2.4 Symptomatic and functioning data 
The functional level at baseline was assessed with the Social and Occupational Functioning Assessment 
Scale (SOFAS; American Psychiatric Association, 1994) and the Global Assessment of Functioning 
(GAF; American Psychiatric Association, 1994). While the SOFAS focuses on social and occupational 
levels, the GAF also includes the impact of symptomatology. Psychotic, depressive, manic symptoms 
and insight were assessed at 2, 6, 12, 18, 24, 30, 36 months follow-up. Insight was also measured at 
baseline. Psychotic symptoms were assessed using the positive and negative symptom subscales of the 
Positive and Negative Psychotic Syndrome Scale (PANSS; Kay, Fiszbein, & Opler, 1987). We 
measured the severity of depressive symptoms using the Montgomery-Asberg Depression Rating Scale 
(MADRS; Montgomery & Asberg, 1979), and manic symptoms with the Young Mania Rating scale 
(YMRS; Young, Biggs, Ziegler, & Meyer, 1978). As the YMRS, MADRS and PANSS scores were not 
available at baseline in our data, we used the assessment at 2 months as a measure of the level of 
symptoms at the beginning of the program. Adherence to treatment was repeatedly assessed on a 3-point 
scale with 1 corresponding to non adherence (0 – 25% of prescribed medication taken), 2 to partial 
adherence (25-75% of prescribed medication taken) and3 to full adherence (75-100% of prescribed 
medication taken). 
2.5 Outcomes at discharge 
We assessed quality of life at discharge with the World Health Organization Quality Of Life scale ("The 
World Health Organization Quality of Life assessment (WHOQOL): position paper from the World 
Health Organization," 1995).  It measures satisfaction with life and self-esteem through 26 self-rated 
items with 5-point Likert scales ranging from 1 (low satisfaction) to 5 (high satisfaction). We used 8 
items of the PANSS (delusion, unusual thought content, hallucinatory behaviour, conceptual 
disorganization, mannerisms, blunted affect, social withdrawal, lack of spontaneity; Andreasen et al., 
2005) following Andreasen’s Criteria (score ≤ 3) to determine symptomatic recovery. A PAS score 
equal or lower to the premorbid rating on four of the five PAS general scale’s items defined functional 
recovery (Strakowski et al., 1998). The assessment of independent living recovery (head of 
household/living alone, with partner, or with peers/living with family with minimal supervision) was 
carried out using the Modified Vocational Status Index (MVSI) and working recovery (paid or unpaid 
full- or part-time employment/being an active student in school or university/head of household with 
employed partner (homemaker)/full or part-time volunteer) using the Modified Location Code Index 
Independent living (MLCI; Tohen et al., 2000). Insight recovery was defined as full insight at discharge. 
2.6 Statistical analysis 
A series of exploratory logistic regression analyses were conducted with the sub-group affective 
psychosis (Yes/No) as the dependent variable, and the individual premorbid and baseline variables as 
predictors (one at a time for each model). We first conducted logistic regression analysis on the main 
socio-demographic measures (age, gender, SES, DUP) to explore statistical differences between 
affective and non-affective psychosis and identify control variables. Because the affective and non-
affective psychosis differed for gender and DUP, these two variables were also included in the models. 
The course of symptoms (positive, negative, depressive, manic) and insight over time were compared 
between sub-groups using exploratory mixed effects models repeated measures analysis of variance 
(MMRM). In these models, the “within-group” factor was time and the “between-groups” factor was 
the sub-group. From the model, the main effects of affective psychosis and time can be examined as 
well as their interaction. Main effects were examined only if the interaction term was not significant. 
We selected the optimal within-subject covariance matrix in each MMRM with the Akaike Information 
Criterion (AIC) coefficient. We tested for any effect of adherence to treatment during follow-up with 
Chi-Square tests at each time point. Finally, to assess outcome differences between affective and non-





3.1 Patient sample 
Our sample consisted of 368 patients. Patients diagnosed with unspecified psychosis were excluded, 
yielding a final sample of 330 patients, composed of 74 patients (22.42%) who met diagnostic criteria 
for affective psychosis (24 with bipolar disorder, 17 with major depression with psychotic features, 33 
with schizoaffective disorder) and 256 (77.58%) who met diagnostic criteria for non-affective psychosis 
(209 with schizophrenia, 47 with schizophreniform disorder). We examined the diagnostic stability over 
the program, we found that only 2.3% of the patients diagnosed with a non-affective psychosis at 18 
months changed to a diagnosis of affective psychosis at 36 months, and none of those diagnosed with 
an affective psychosis at 18 months changed to a diagnosis of non-affective psychosis at 36 months. 
3.2 Socio-demographic and premorbid characteristics 
Socio-demographic and premorbid characteristics are reported in Table 1. There was significantly more 
females in the affective psychosis group (p = .008). Patients with affective psychosis displayed a 













ORa 95% CI of ORa p-value 







Gender, male % (N) 64.2 (212) 50.0 (37) 68.4 (175) 2.053 1.202 3.506 .008* 






1.032 .975 1.093 .281 






1.030 .974 1.088 .299 
Duration of untreated psychosis 







.597 .429 .831 .002* 
Socio-economical level, % (N)    1.073 .744 1.548 .706 
Low 37.3 (123) 37.8 (28) 31.7 (95)     
Intermediate 43.6 (144) 41.9 (31) 44.1 (113)     
High 19.1 (63) 20.3 (15) 48.8 (18)     
Living situation, % (N)    1.196 .670 2.135 .544 
Independent 67.8 (217) 67.1 (49) 68.0 (168)     
Others 32.2 (103) 32.9 (24) 32.0 (79)     
Employment situation, % (N)        
Active 14.4 (47) 18.1 (13) 13.4 (34) Ref.cat - - - 
Student/Traineeship 17.8 (58) 26.4 (19) 15.4 (39) 1.293 .543 3.078 .562 
Others 67.8 (221) 55.6 (40) 71.3 (181) .678 .321 1.429 .307 




9.96 (2.804) 1.071 .958 1.198 
 
.228 
Marital status, % (N)  
 
      
Single 84.0 (272) 78.1 (57) 85.7 (215) Ref.cat - - - 
Married 9.0 (29) 12.3 (9) 8.0 (20) 1.568 .642 3.826 .323 
Divorced 3.4 (11) 6.8 (5) 2.4 (6) 2.660 .736 9.609 .136 
Cohabitation 3.7 (12) 2.7 (2) 4.0 (10) .623 .129 3.013 .556 







.426 .078 2.337 .326 













.668 .102 4.355 .673 
Past suicide attempt, % (N) 13.6 (43) 16.4 (12) 12.7 (31) 1.311 .615 2.792 .483 
History of traumab, % (N) 27.8 (91) 26.8 (19) 28.1 (72) .847 .456 1.571 .598 
Migration in adversity, % (N) 30.9(102) 37.8(28) 28.9(74) 1.481 .845 2.593 .170 
Psychiatric history, % (N) 59.9 (194) 50.7 (37) 62.5 (157) .656 .376 1.143 .137 
Familial psychiatric history, % 
(N) 
57.5 (176) 62.9 (44) 55.9 (132) 1.152 .801 1.658 .445 
Lifetime substance abuse (DSM-
IV), % (N) 
53.2 (174) 46.6 (34) 55.1 (140) .824 .475 1.427 .490 
Forensic history, % (N) 13.5 (39) 11.3 (7) 14.1 (32) .995 .395 2.504 .991 
Note. N = total number. M = mean. SD = standard deviation. Mdn = median. IQR = Interquartile range. CI = confidence 
interval. Ref.cat = reference category. a = Raw data are presented, however the test statistics were based on log10 (+constant) 
transformed data because of extreme positive skewness; b physical or sexual abuse. All models were adjusted for gender and 
duration of untreated psychosis; ORa = Adjusted odds ratio. Quantitative variables were treated as continuous variables. We 










3.3 Symptomatic and functional characteristics at the beginning of the program 
There was no significant difference between sub-groups regarding symptoms and functioning at entry 
(Table 2).  






ORa 95% CI of ORa p-value 













.998 .982 1.015 .834 






1.001 .985 1.017 .920 
YMRS at the beginning, M (SD) 6.58 (5.805) 6.03 
(5.398) 
6.83 (6.137) .973 .904 1.048 .474 
MADRS at the beginning, M (SD) 15.91 (9.770) 17.47 
(11.404) 
15.19 (9.219) 1.029 .985 1.074 .198 
PANSS at the beginning, M (SD)        
Positive 13.67 (4.862) 12.77 
(4.240) 
13.99 (5.158) .953 .873 1.041 .283 
Negative 15.95 (6.070) 15.23 
(5.271) 
16.54 (6.299) .966 .899 1.037 .333 
General 34.52 (8.162) 34.39 
(6.859) 
34.61 (8.621) .994 .945 1.045 .812 
Insight at baseline, % (N)    .996 .687 1.443 .983 
Full 20.4 (65) 22.5 (16) 19.8 (49)     
Partial 45.8 (146) 42.3 (30) 46.8 (116)     
Null 33.9 (108) 35.2 (25) 33.5 (83)     
Note. N = total number. M = mean. SD = standard deviation. CI = confidence interval. SOFAS, Social and Occupational 
Functioning Scale; GAF, Global Assessment of Functioning scale; YMRS, Young Mania Rating Scale; MADRS, 
Montgomery-Asberg Depression Rating Scale; PANSS, Positive and Negative Syndrome Scale. All models were adjusted for 
gender and duration of untreated psychosis; ORa = Adjusted odds ratio. Quantitative variables were treated as continuous 
variables. We used affective psychosis as the reference category of the dependent variable. * p<.05. 
 
3.4 Clinical course of psychotic, depressive, manic symptoms and insight over time 
The course of symptoms over time differed between affective and non-affective psychosis. The level of 
positive symptoms over the three years was significantly higher in the non-affective sub-group (mean 
difference = 1.502, df = 262.048, p = .006; Figure 1.A.). Negative symptoms did not differ significantly 
(mean difference = 1.339, df = 234.047, p = .068, Figure 1.B). 
Figure 1. Course of positive (A.) and negative (B.) symptoms of affective (N=74) and non-affective 
psychosis (N=256) across the 36 months follow-up 
The variability of manic symptoms over the course of the program was high in the affective psychosis 
group whereas this dimension remained stable in non-affective psychosis (Figure 2.A.). As a result,  
affective and non-affective psychosis differed both at 6 months (mean difference = 1.887, df = 150.161, 
p = .037) and at 18 months (mean difference = 2.425, df = 153.553, p = .031) in this regard. The course 
and level of depressive symptoms (Figure 2.B.) did not differ significantly between the sub-groups 
(mean difference = -1.379, df = 258.234, p = .223). While the level of insight was similar between 
affective and non-affective psychosis at the beginning of the program, it differed significantly after 6 
months (mean difference = -.206, df = .087, p = .019; Figure 2.C.), the affective sub-group displaying 
a higher level of insight. This difference was maintained all along the follow-up. We did not find any 
significant differences between affective and non-affective psychosis on adherence to treatment at any 
time point of the follow-up. 
 
Figure 2.  Course of manic (A.), depressive (B.) symptoms and insight (C.) of affective (N=74) and non-
affective psychosis (N=256) across the 36 months follow-up 
3.5 Outcome differences at discharge 
Results regarding outcome at discharge are reported in Table 3. Patients in the affective psychosis sub-
group perceived the quality of their environment as better than in the non-affective sub-group (p = .007). 
Furthermore, patients with affective psychosis had developed a higher level of insight towards the end 
of the treatment period than those with non-affective psychosis (p = .005). No other significant 

















95% CI of ORa 
p-value 
LCI UCI 
Quality of life       
Quality of physical 
health, M (SD) 
25.90 
(5.05) 
25.08 (4.38) .997 .885 1.124 .962 
Quality of 
psychological 
aspects, M (SD) 
21.88 
(4.43) 
21.66 (3.44) 1.011 .879 1.162 .881 











27.91 (5.91) 1.172 1.047 1.311 .006* 
Symptomatic recovery, % (N) 51.9 (14) 44.2 (46) 1.024 .405 2.586 .960 
General functional recovery, 
% (N) 
53.4 (31) 40.7 (83) 1.433 .779 2.636 .247 
Premorbid adjustment 
recovery, % (N) 
52.5 (21) 43.4 (62) 1.228 .591 2.550 .582 
Working recovery, % (N) 27.6 (16) 27.4 (52) .745 .370 1.499 .409 
Independent living recovery, 
% (N) 
74.1 (43) 55.3 (105) 1.940 .987 3.813 .055 
Insight recovery, % (N) 71.4 (40) 49.7 (88) 2.200 1.125 4.302 .021* 
Note. N = total number. M = mean. SD = standard deviation. CI = confidence interval. LCI = Lower limit of the confidence 
interval; UCI = Upper limit of the confidence interval. All models were adjusted for gender and duration of untreated 
psychosis; ORa = Adjusted odds ratio. Quantitative variables were treated as continuous variables. We used affective 





Our study aimed at exploring the clinical relevance of the dichotomy between affective and non-
affective psychosis in a first episode psychosis sample. Based on our data, and despite many 
commonalities both at baseline and over the follow-up, in addition to gender and DUP previously 
reported (Conus et al., 2007; Kapila et al., 2019; Schothorst et al., 2006), these two sub-groups differed 
significantly regarding the course of positive, manic symptoms and insight, elements which might justify 
the development of distinct therapeutic approaches. 
First, our results revealed important differences between affective and non-affective psychosis regarding 
the course of symptoms. Despite a similar trajectory, the level of positive psychotic symptoms remained 
higher in the non-affective sub-group. However, we did not find any differences between sub-groups 
regarding negative symptoms. These results are partially in line with previous studies comparing 
affective and non-affective groups, and reporting higher levels of both negative and positive symptoms 
at follow-up for the non-affective one (Henry et al., 2010; Kapila et al., 2019; Torrent et al., 2018).  
However, contrary to these previous studies, our study observed the course of psychotic symptoms over 
a three-year follow-up. Considering the crucial role of negative symptoms in long-term recovery (Austin 
et al., 2013), the absence of difference between affective and non-affective psychosis highlights the risk 
of poor long-term outcome in both disorders, confirming a challenging recovery previously reported in 
affective psychosis as well (Conus et al., 2010; Conus et al., 2006; Conus & McGorry, 2002).  Our 
results suggest that positive symptoms remain the main distinctive symptomatic feature of non-affective 
psychosis. However, we did not investigate symptomatic trajectories within affective and non-affective 
psychosis to identify different patterns like previously found (Austin et al., 2015), it would thus be 
interesting to further explore the heterogeneity in the course of positive symptoms to develop targeted 
intervention. Moreover, considering mood symptoms, we found no difference in the course of depressive 
symptoms between affective and non-affective psychosis, and found that only the variability of manic 
symptoms was more important in affective psychosis. Previous literature on schizoaffective disorder 
reported similarities regarding treatment between schizophrenia and schizoaffective disorders, 
 
 
especially depressed type (Keck, McElroy, & Strakowski, 1996), as well as similar outcome between 
schizoaffective disorder, major depression, and schizophrenia (Coryell, Grove, Keller, & Endicott, 
1987). These results therefore suggest that the manic dimension may play an important role to 
differentiate affective from non-affective psychosis rather than the depressive one. Further investigation 
of such specificities within affective psychoses are however required to identify those not displaying the 
full blown mania syndrome considering that they are at risk of delayed identification (Arrasate et al., 
2014; Conus, 2010) despite requiring specific treatment (Strakowski et al., 1998). 
Second, we observed that patients with affective psychosis were more likely to develop insight over the 
treatment period than those with non-affective psychosis. Indeed, we found an early improvement of 
insight in the affective psychosis sub-group, which was significantly better after 6-month follow-up. 
This might be linked to the trait like condition of insight in non-affective psychosis contrasting with a 
state-dependent insight (Ghaemi & Rosenquist, 2004) associated with greater fluctuations of manic 
symptoms in affective psychosis, allowing for phases of full symptom recovery. Development of insight 
remains challenging in early psychosis, especially among patients with non-affective psychosis 
(Keshavan, Rabinowitz, DeSmedt, Harvey, & Schooler, 2004). 
Third, regarding clinical data at entry, and as already reported previous publications (Conus et al., 2007; 
Kapila et al., 2019; Schothorst et al., 2006), gender and DUP differed significantly between affective 
and non-affective psychosis with a higher rate of women and a shorter DUP in the affective psychosis 
sub-group. However, contrary to these studies, we did not find any difference between groups regarding 
suicide attempts, past history of psychiatric disorder or substance use, premorbid functioning or 
adjustment, or psychotic and manic symptoms at baseline. Our results therefore suggest that premorbid 
and socio-demographic information may not provide clues to identify patients who will develop 
affective or non-affective psychosis contrary to previous findings regarding diagnosis identification 
(Kapila et al., 2019).  
Fourth, while previous studies reported a better functioning and symptomatic recovery in affective than 
in non-affective psychosis (Kapila et al., 2019), our study did not reveal such differences. Nevertheless, 
this is in line with other studies suggesting that outcome in affective psychoses is not as good as 
 
 
previously thought, especially regarding functioning (Conus et al., 2006). However, despite the absence 
of differences between sub-groups regarding clinical recovery, we found that the sub-group with 
affective psychosis had a better quality of environment at discharge. This may be linked to the fact that 
this subgroup had also a shorter DUP previously reported to be associated with a better quality of life 
(Marshall et al., 2005). 
Finally, our findings suggest overall that affective and non-affective psychosis might benefit from 
specific intervention strategies like previously reported (Berk et al., 2017; Lambert et al., 2003). For 
example, a previous study on first-episode bipolar disorder reported that these patients benefit more of 
a mood stabilizer like lithium as maintenance treatment rather than an antipsychotic like quetiapine 
(Berk et al., 2017). In addition to treatment, Kessing et al. (2013) reported that patients in the early 
course of bipolar disorder may benefit from a specialized out-patients mood disorder clinic rather than 
standard care. However, further studies including schizoaffective disorder, major depression with 
psychotic features, and bipolar disorder patients are required to explore whether or not these patients 
with affective psychoses may benefit from a specific intervention targeting mood disorders. 
Our results must be interpreted with some degree of caution due to various limitations. First, the six 
months interval between assessments may not enable to catch the complete feature of the course of 
symptoms through the early phase of illness. It would be interesting to study the course of mood 
symptoms with a greater sampling resolution and shorter time interval to better understand their 
temporal dynamic. Second, scores on the YMRS scale might be driven by symptoms such as delusions, 
insight and aggressive behaviour, rather than by specific manic symptoms, thus the similar levels of 
both groups on this scale must be considered with cautious. Third, we used the 2-month measures for 
the YMRS, MADRS, and PANSS as baseline measures which may not provide a very accurate baseline 
clinical picture. Indeed, during the first two months, treatment and case management follow-up are 
introduced providing the first steps for stabilization. Therefore, these measures do not reflect the acute 
baseline symptomatic picture of first episode patients, and may thus hide some clinical differences 
between affective and non-affective psychosis patients. However, the PANSS, YMRS, and MADRS 
measures were not available at baseline. Finally, differences between affective and non-affective 
 
 
psychosis regarding the course of symptoms might be influenced be other variables that were not tested, 
like the type of medication. This would require further investigation. 
 
5. Conclusion 
Our study aimed to investigate the clinical relevance of a differentiation between affective and non-
affective psychosis, and the results suggest that while this differentiation is challenging at baseline, it is 
nevertheless relevant, considering that these two groups display significant differences regarding their 
longitudinal trajectories and outcome. More studies are needed to explore the potential impact of a 
specification of intervention in both of these sub-groups. 
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